2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
4
Lung Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pain
2
Lymphoma
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Postoperative Hemorrhage
1
Polyposis, Gastric
1
Oropharyngeal Neoplasms
1
Nerve Block
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Musculoskeletal Diseases
1
Multiple Myeloma
1
Mouth Neoplasms
1
Malignant Neoplasms of Male Genital Organs
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Leukemia
1
Leiomyoma
1
Hypotension
1
Hodgkin Disease
1
Interventions
Bupivacaine
2
acetaminophen, codeine drug combination
1
Triiodothyronine
1
Tramadol
1
Thyroxine
1
Thyroidectomy
1
Ropivacaine
1
Remote Consultation
1
Negative-Pressure Wound Therapy
1
Ketorolac
1
Indocyanine Green
1
Hyaluronic Acid
1
Glucose
1
Epinephrine
1
Dexmedetomidine
1
Data Collection
1
Clinical Protocols
1
Capsules
1
Calcium Carbonate
1
Calcitriol
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Goiter
×
Epinephrine
×
Clear all
NCT02112370
2017-08-04
REBT
Seoul National University Hospital
Phase 3
Completed
148 enrolled
17 charts